Latest Updates of Companies in the U.S. Liquid Vaccine Filling Solutions Market
| Company | Headquarters | Latest Update |
| Stevanato Group | United States | Stevanato Group continued to strengthen its position as a significant provider of integrated liquid vaccine filling services and high-value containment technology. |
| Lonza Group | United States | Lonza to support the development and manufacturing of ImmuneOncia's Danburstotug with a complete and combined end-to-end drug substance. |
| Catalent, Inc. | United States | Catalent provides end-to-end healthcare solutions as a trusted CDMO, advancing drug development and manufacturing globally. |
| Vetter Pharma | United States | Vetter, a healthcare service worker for the production of injectable drugs, has confirmed its plans to build a production capability. |
Recent Developments in the U.S. Liquid Vaccine Filling Solutions Market
- In May 2026, Syntegon presented a novel line concept for liquid pharmaceuticals. SynTiso was developed in partnership with two partners from the pharmaceutical industry and addresses the current limitation of pharmaceutical manufacturers regarding high performance and availability, as well as maximum product yield and minimal operator involvement.
- In October 2025, Aenova announced a significant investment in its sterile manufacturing capabilities with the installation of another fill & finish line at its Latina site. This development marks an imperative step in meeting the increasing worldwide demand for biologics production.
- In July 2025, Sanofi announced it had agreed to acquire Vicebio Ltd, a privately held biotechnology organization headquartered in London, UK.
Supply Chain Analysis
R&D:
- Research and development (R&D) in liquid vaccine filling solution includes formulation development and stability, primary packaging compatibility, filling process development and optimization, sterilization and aseptic techniques, scale-up and transfer to production, and container closure integrity (CCI) studies
- Key Players: Syntegon and IMA Group
Manufacturing Processes:
- Manufacturing processes involve sterilization, formulation, filling, and sealing in a continuous, often automated, operation.
- Key Players: Optima Packaging Group and Groninger & Co. GmbH
Patient Services:
- Patient services in liquid vaccine filling are significantly focused on ensuring the sterility, safety, effectiveness, and availability of the vaccine.
- Key Players: Dara Pharma and Cozzoli Machine Company
Market Growth
The U.S. liquid vaccine filling solutions market size was estimated at USD 1.42 billion in 2025 and is predicted to increase from USD 1.56 billion in 2026 to approximately USD 3.63 billion by 2035, expanding at a CAGR of 9.85% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking